<DOC>
	<DOCNO>NCT00310466</DOCNO>
	<brief_summary>The trial perform assess efficacy safety SLIT One birch treatment birch pollen induce allergy</brief_summary>
	<brief_title>Efficacy Safety Trial SLITone ( TM ) Birch Subjects With Hayfever</brief_title>
	<detailed_description>Daily rhinoconjunctivits symptom medication score patient diary , adverse event</detailed_description>
	<criteria>A history birch pollen allergy Positive skin prick test birch Positive conjunctival test birch Positive specific Immunoglobulin E ( IgE ) birch Forced expiratory volume 1 second ( FEV1 ) &lt; 70 % predict value History seasonal allergy interfere study History symptomatic perennial allergy History emergency visit admission asthma previous 12 month</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>April 2013</verification_date>
</DOC>